South Korea's Green Cross heads for China; India's Nutraplus adding API production;

> Charles River Laboratories today announced that its contract manufacturing revenues were down in the first quarter. Release

> India's Nutraplus says it will build to API plants. Report

> South Korea's Green Cross said it intends to build a cell therapy manufacturing facility at the Guian New Area in the Guizhou province of China. Release